Medical Science Liaison - Oncology

Core Responsibilities

• Deliver balanced, data-driven discussion of the clinical, pharmacologic, and pharmacokinetic profile of assets in the therapeutic area to academic and community oncologists; respond to unsolicited requests for information within approved processes.
• Map, segment, and engage national and regional key opinion leaders; own a defined set of leader relationships and maintain engagement plans against clear scientific objectives.
• Plan and execute advisory boards, participate in congress activity, and support abstract, publication, and podium planning sequenced against evidence milestones.
• Manage a territory built on oncology density rather than geography — typically 12-15 priority academic and network accounts — prioritizing institutions that control pathway and formulary decisions above raw volume.
• Facilitate investigator-initiated study discussions, support real-world evidence and outcomes research activity, and identify data gaps the current evidence base does not close.
• Provide the scientific input that supports compendia recognition and clinical pathway inclusion, partnering with medical leadership on submission content and post-decision maintenance.
• Capture and report field insights on treatment sequencing, unmet need, and competitive landscape to inform medical, HEOR, and access strategy.
• Partner with market access on dossier and pathway pull-through and with commercial partners on scientific accuracy, maintaining a clear separation between medical and promotional activity.

Required Qualifications

• Advanced doctoral degree — PharmD, PhD, or MD, NP/PA
• Field medical experience in oncology, or equivalent clinical/scientific experience
• Demonstrated ability to hold peer-level scientific conversations with academic investigators
• Willingness to travel extensively across a national, field-based territory

Core Competencies

• Therapeutic depth. Fluency in solid-tumor oncology — treatment sequencing, combination regimens, and the evidentiary limits of what a given data set can and cannot claim.
• Scientific credibility. Able to earn and hold the respect of investigators and guideline authors as a scientific peer, not a communicator of messages.
• Compliance discipline (non-negotiable). Rigorous on the promotional boundary — unsolicited-request handling, off-label limits, and pre-approval information exchange rules.
• Independent judgment. Able to run advisory boards, congress engagement, and study discussions independently with minimal oversight.
• Strategic account thinking. Understands how academic centers drive community prescribing and how institutional pathway committees actually decide.
• Collaboration without role drift. Works closely with access and commercial functions while maintaining medical independence.

Success Measures — First 12 Months

• Depth and quality of KOL and priority-account engagement
• Quality and actionability of field insights
• Contribution to evidence and publication milestones
• Support of compendia and pathway submissions